$493 Million is the total value of Samsara BioCapital, LLC's 44 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JYAC | New | Jiya Acquisition Corp | $507,041,000 | – | 5,223 | +100.0% | 50.99% | – |
| KDNY | New | Chinook Therapeutics Inc | $50,251,000 | – | 3,168,388 | +100.0% | 5.05% | – |
| COGT | New | Cogent Biosciences Inc | $6,614,000 | – | 588,961 | +100.0% | 0.66% | – |
| KRON | New | Kronos Bio Inc | $4,966,000 | – | 166,250 | +100.0% | 0.50% | – |
| BLSA | New | BCLS Acquisition Corp | $3,342,000 | – | 300,000 | +100.0% | 0.34% | – |
| VTGN | New | Vistagen Therapeutics Inc | $3,182,000 | – | 1,640,368 | +100.0% | 0.32% | – |
| CHFWU | New | Consonance HFW Acquisition Co | $3,141,000 | – | 300,000 | +100.0% | 0.32% | – |
| AVDL | New | Avadel Pharmaceuticals PLCspons adr | $2,901,000 | – | 434,250 | +100.0% | 0.29% | – |
| LSAQ | New | Lifesci Acquisition II Corp | $2,134,000 | – | 200,000 | +100.0% | 0.22% | – |
| SBTX | New | Silverback Therapeutics Inc | $1,159,000 | – | 25,000 | +100.0% | 0.12% | – |
| KDMN | New | Kadmon Hldgs Inc | $685,000 | – | 165,000 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.